Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/54/7c/b4/547cb433-faa2-e528-a62c-44b129cb223d/mza_2915872245149821434.jpg/600x600bb.jpg

Clinician's Roundtable

ReachMD

3194 episodes

1 day ago

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.

Science

Medicine

RSS

All content for Clinician's Roundtable is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential

Clinician's Roundtable

3 weeks ago

Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential

Host: Ryan Quigley

In a 2025 study investigating salivary metabolites as potential biomarkers in cystic fibrosis, researchers identified distinct metabolic patterns linked with key complications as well as correlations with lung function. In this AudioAbstract, Ryan Quigley discusses how a simple saliva sample could provide clinicians with an accessible, non-invasive tool to stratify patients, monitor therapies, and advance personalized care in cystic fibrosis. This topic was also discussed at the 2025 CHEST Annual Meeting.